TP53 and urinary bladder carcinoma: According to above researches, we have found that TP53 mutation and some other important gene mutations could influence multiple cancer‐relative signal pathway of bladder cancer and finally promoted the progress and development of bladder cancer, which made TP53 mutation a potential and newly therapeutic target.